Captopril and norepinephrine-induced hypertrophy and haemodynamics in rats

S. K. Laycock, K. A. Kane, J. McMurray, J. Parratt

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

We wished to determine whether pretreatment with captopril, an angiotension-converting enzyme (ACE) inhibitor, modified the myocardial and haemodynamic consequences of chronic administration of norepinephrine (NE) in rats. Administration of NE (0.15 mg kg-1 h-1 by an osmotic minipump implanted subcutaneously for 28 days) resulted in left but not right ventricular hypertrophy. Captopril (250 but not 52 μg kg-1 h-1 administered for 28 days) significantly attenuated the development of left ventricular hypertrophy (weight of left ventricle to body weight ratio was 0.46 ± 0.01, 0.57 ± 0.02, 0.53 ± 0.02, and 0.51 ± 0.01 for vehicle, NE, and NE plus low and high dose of captopril, respectively). Chronic administration of NE caused significant increases m systolic arterial blood pressure (BP: 194 ± 11 vs. 130 ± 6 mm Hg), systolic left ventricular pressure, heart rate (HR: 458 ± 13 vs. 389 ± 15 beats/min) and dP dt- 1(max) P-1, an index of myocardial contractility (202 ± 29 vs. 91 ± 3 s-1). Captopril (250 μg kg-1 h-1 for 28 days) significantly reduced diastolic arterial BP (from 86 ± 6 to 53 ± 3 mm Hg). Concomitant administration of this dose of captopril together with NE prevented the NE- induced increase in systolic arterial BP but did not modify the increases in HR or dP dt-1(max) P-1 (261 ± 41 and 202 ± 29 s-1 in captopril and NE vs. NE-alone groups). Acute administration of NE (0.1-10 μg kg-1 intravenously, i.v.) produced less marked increases in cardiac contractility and in arterial BP in rats chronically pretreated with NE or NE plus captopril than in animals receiving vehicle or captopril alone. Chronic administration of NE and/or captopril did not significantly modify the haemodynamic effects of the acute administration of calcium chloride. We conclude that administration of captopril at 250 but not 52 μg kg-1 h-1 for 28 days attenuates NE-induced cardiac hypertrophy and that this effect is associated with a decrease in systolic arterial BP. Captopril did not modify the reduced effects of acutely administered NE in rats treated with NE for a prolonged period.

Original languageEnglish
Pages (from-to)667-672
Number of pages6
JournalJournal of Cardiovascular Pharmacology
Volume27
Issue number5
DOIs
Publication statusPublished - 1996

Fingerprint

Captopril
Hypertrophy
Norepinephrine
Hemodynamics
Right Ventricular Hypertrophy
Calcium Chloride
Cardiomegaly
Left Ventricular Hypertrophy
Enzyme Inhibitors
Ventricular Pressure
Heart Ventricles

Keywords

  • Chronic captopril
  • Chronic norepinephrine
  • Haemodynamics
  • Hypertrophy
  • Rats

ASJC Scopus subject areas

  • Pharmacology
  • Cardiology and Cardiovascular Medicine

Cite this

Captopril and norepinephrine-induced hypertrophy and haemodynamics in rats. / Laycock, S. K.; Kane, K. A.; McMurray, J.; Parratt, J.

In: Journal of Cardiovascular Pharmacology, Vol. 27, No. 5, 1996, p. 667-672.

Research output: Contribution to journalArticle

Laycock, S. K. ; Kane, K. A. ; McMurray, J. ; Parratt, J. / Captopril and norepinephrine-induced hypertrophy and haemodynamics in rats. In: Journal of Cardiovascular Pharmacology. 1996 ; Vol. 27, No. 5. pp. 667-672.
@article{040693c62a24425cad4e5ee09e5d488d,
title = "Captopril and norepinephrine-induced hypertrophy and haemodynamics in rats",
abstract = "We wished to determine whether pretreatment with captopril, an angiotension-converting enzyme (ACE) inhibitor, modified the myocardial and haemodynamic consequences of chronic administration of norepinephrine (NE) in rats. Administration of NE (0.15 mg kg-1 h-1 by an osmotic minipump implanted subcutaneously for 28 days) resulted in left but not right ventricular hypertrophy. Captopril (250 but not 52 μg kg-1 h-1 administered for 28 days) significantly attenuated the development of left ventricular hypertrophy (weight of left ventricle to body weight ratio was 0.46 ± 0.01, 0.57 ± 0.02, 0.53 ± 0.02, and 0.51 ± 0.01 for vehicle, NE, and NE plus low and high dose of captopril, respectively). Chronic administration of NE caused significant increases m systolic arterial blood pressure (BP: 194 ± 11 vs. 130 ± 6 mm Hg), systolic left ventricular pressure, heart rate (HR: 458 ± 13 vs. 389 ± 15 beats/min) and dP dt- 1(max) P-1, an index of myocardial contractility (202 ± 29 vs. 91 ± 3 s-1). Captopril (250 μg kg-1 h-1 for 28 days) significantly reduced diastolic arterial BP (from 86 ± 6 to 53 ± 3 mm Hg). Concomitant administration of this dose of captopril together with NE prevented the NE- induced increase in systolic arterial BP but did not modify the increases in HR or dP dt-1(max) P-1 (261 ± 41 and 202 ± 29 s-1 in captopril and NE vs. NE-alone groups). Acute administration of NE (0.1-10 μg kg-1 intravenously, i.v.) produced less marked increases in cardiac contractility and in arterial BP in rats chronically pretreated with NE or NE plus captopril than in animals receiving vehicle or captopril alone. Chronic administration of NE and/or captopril did not significantly modify the haemodynamic effects of the acute administration of calcium chloride. We conclude that administration of captopril at 250 but not 52 μg kg-1 h-1 for 28 days attenuates NE-induced cardiac hypertrophy and that this effect is associated with a decrease in systolic arterial BP. Captopril did not modify the reduced effects of acutely administered NE in rats treated with NE for a prolonged period.",
keywords = "Chronic captopril, Chronic norepinephrine, Haemodynamics, Hypertrophy, Rats",
author = "Laycock, {S. K.} and Kane, {K. A.} and J. McMurray and J. Parratt",
year = "1996",
doi = "10.1097/00005344-199605000-00008",
language = "English",
volume = "27",
pages = "667--672",
journal = "Journal of Cardiovascular Pharmacology",
issn = "0160-2446",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Captopril and norepinephrine-induced hypertrophy and haemodynamics in rats

AU - Laycock, S. K.

AU - Kane, K. A.

AU - McMurray, J.

AU - Parratt, J.

PY - 1996

Y1 - 1996

N2 - We wished to determine whether pretreatment with captopril, an angiotension-converting enzyme (ACE) inhibitor, modified the myocardial and haemodynamic consequences of chronic administration of norepinephrine (NE) in rats. Administration of NE (0.15 mg kg-1 h-1 by an osmotic minipump implanted subcutaneously for 28 days) resulted in left but not right ventricular hypertrophy. Captopril (250 but not 52 μg kg-1 h-1 administered for 28 days) significantly attenuated the development of left ventricular hypertrophy (weight of left ventricle to body weight ratio was 0.46 ± 0.01, 0.57 ± 0.02, 0.53 ± 0.02, and 0.51 ± 0.01 for vehicle, NE, and NE plus low and high dose of captopril, respectively). Chronic administration of NE caused significant increases m systolic arterial blood pressure (BP: 194 ± 11 vs. 130 ± 6 mm Hg), systolic left ventricular pressure, heart rate (HR: 458 ± 13 vs. 389 ± 15 beats/min) and dP dt- 1(max) P-1, an index of myocardial contractility (202 ± 29 vs. 91 ± 3 s-1). Captopril (250 μg kg-1 h-1 for 28 days) significantly reduced diastolic arterial BP (from 86 ± 6 to 53 ± 3 mm Hg). Concomitant administration of this dose of captopril together with NE prevented the NE- induced increase in systolic arterial BP but did not modify the increases in HR or dP dt-1(max) P-1 (261 ± 41 and 202 ± 29 s-1 in captopril and NE vs. NE-alone groups). Acute administration of NE (0.1-10 μg kg-1 intravenously, i.v.) produced less marked increases in cardiac contractility and in arterial BP in rats chronically pretreated with NE or NE plus captopril than in animals receiving vehicle or captopril alone. Chronic administration of NE and/or captopril did not significantly modify the haemodynamic effects of the acute administration of calcium chloride. We conclude that administration of captopril at 250 but not 52 μg kg-1 h-1 for 28 days attenuates NE-induced cardiac hypertrophy and that this effect is associated with a decrease in systolic arterial BP. Captopril did not modify the reduced effects of acutely administered NE in rats treated with NE for a prolonged period.

AB - We wished to determine whether pretreatment with captopril, an angiotension-converting enzyme (ACE) inhibitor, modified the myocardial and haemodynamic consequences of chronic administration of norepinephrine (NE) in rats. Administration of NE (0.15 mg kg-1 h-1 by an osmotic minipump implanted subcutaneously for 28 days) resulted in left but not right ventricular hypertrophy. Captopril (250 but not 52 μg kg-1 h-1 administered for 28 days) significantly attenuated the development of left ventricular hypertrophy (weight of left ventricle to body weight ratio was 0.46 ± 0.01, 0.57 ± 0.02, 0.53 ± 0.02, and 0.51 ± 0.01 for vehicle, NE, and NE plus low and high dose of captopril, respectively). Chronic administration of NE caused significant increases m systolic arterial blood pressure (BP: 194 ± 11 vs. 130 ± 6 mm Hg), systolic left ventricular pressure, heart rate (HR: 458 ± 13 vs. 389 ± 15 beats/min) and dP dt- 1(max) P-1, an index of myocardial contractility (202 ± 29 vs. 91 ± 3 s-1). Captopril (250 μg kg-1 h-1 for 28 days) significantly reduced diastolic arterial BP (from 86 ± 6 to 53 ± 3 mm Hg). Concomitant administration of this dose of captopril together with NE prevented the NE- induced increase in systolic arterial BP but did not modify the increases in HR or dP dt-1(max) P-1 (261 ± 41 and 202 ± 29 s-1 in captopril and NE vs. NE-alone groups). Acute administration of NE (0.1-10 μg kg-1 intravenously, i.v.) produced less marked increases in cardiac contractility and in arterial BP in rats chronically pretreated with NE or NE plus captopril than in animals receiving vehicle or captopril alone. Chronic administration of NE and/or captopril did not significantly modify the haemodynamic effects of the acute administration of calcium chloride. We conclude that administration of captopril at 250 but not 52 μg kg-1 h-1 for 28 days attenuates NE-induced cardiac hypertrophy and that this effect is associated with a decrease in systolic arterial BP. Captopril did not modify the reduced effects of acutely administered NE in rats treated with NE for a prolonged period.

KW - Chronic captopril

KW - Chronic norepinephrine

KW - Haemodynamics

KW - Hypertrophy

KW - Rats

UR - http://www.scopus.com/inward/record.url?scp=0029913672&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029913672&partnerID=8YFLogxK

U2 - 10.1097/00005344-199605000-00008

DO - 10.1097/00005344-199605000-00008

M3 - Article

C2 - 8859936

AN - SCOPUS:0029913672

VL - 27

SP - 667

EP - 672

JO - Journal of Cardiovascular Pharmacology

JF - Journal of Cardiovascular Pharmacology

SN - 0160-2446

IS - 5

ER -